DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.43−0.45 (-3.79%)
Close on Nov 12, 2026Market cap $718.69MP/E –Yield –
DBV Technologies statistics
76 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 25, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 5.03
- 2.38
Enterprise valuationIndustry
- EV / Sales
- 151.53
- 2.65
Share statisticsIndustry
- Shares Change (YoY)
- 216.3%
- 10.9%
- Float
- 276M
- 49M
- Shares Held by Insiders
- 12.1%
- 12.1%
- Shares Held by Institutions
- 6.85%
- 56.4%
Short sellingIndustry
- Short Interest
- 806,674
- –
- Short Interest Change
- -7.50%
- -0.80%
- Days to Cover
- 1.67
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $26.18
- –
- 52-Week Low
- $8.63
- –
- 20-Day Moving Average
- $10.00
- –
- 50-Day Moving Average
- $10.94
- –
- 200-Day Moving Average
- $16.49
- –
- Average True Range (14)
- $0.71
- –
- Price Change (1 Week)
- 19.5%
- -0.58%
- Price Change (1 Month)
- 31.6%
- -0.28%
- Price Change (3 Months)
- -15.3%
- -17.1%
- Price Change (6 Months)
- -39.4%
- -20.1%
- Price Change (YTD)
- -38.0%
- -20.1%
- Price Change (1 Year)
- -12.5%
- -19.3%
- Price Change (3 Years)
- 536.0%
- -22.2%
- Price Change (5 Years)
- 92.2%
- -76.4%
- Price Change (10 Years)
- -83.9%
- -62.4%
- Average Volume (10 Days)
- 393,125
- –
- Average Volume (20 Days)
- 415,443
- –
- Average Volume (90 Days)
- 350,995
- –
- Relative Volume
- 1.06
- 0.73
- Relative Strength Index (14)
- 64.1
- 47.7
- Volatility (1 Year)
- 71.8%
- 80.2%
- Beta (5 Years)
- 0.58
- 1.08
MarginsIndustry
- Pretax Margin
- -5376.9%
- -11.8%
- EBITDA Margin
- -5431.6%
- -27.7%
- FCF Margin
- -4997.7%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- -205.8%
- -51.3%
- Return on Assets (ROA)
- -127.2%
- -40.7%
- Return on Capital Employed (ROCE)
- -132.8%
- -38.1%
Financial positionIndustry
- Current Ratio
- 3.24
- 3.30
- Quick Ratio
- 2.83
- 2.40
GrowthIndustry
- Revenue Growth (YoY)
- -31.6%
- 7.26%
- Revenue Growth (3Y CAGR)
- 5.18%
- 2.25%
- Revenue Growth (5Y CAGR)
- -13.0%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.02
- 0.40
- Revenue Per Employee
- $30.69K
- $429.38K
- Profits Per Employee
- -$1.66M
- -$683.67K
- Employee Count
- 125
- 75
- WACC
- 7.80%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$206.26M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $165.70M
- $16.56M
- Net Cash Per Share
- $0.53
- $0.71
- Equity (Book Value)
- $148.60M
- $52.23M
- Book Value Per Share
- $0.47
- $1.50
- Tangible Book Value
- $148.60M
- $26.10M
- Working Capital
- $131.10M
- $78.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$3.33M
- -$944.00K
- FCF Per Share
- -$0.61
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- -27.8%
- -20.1%
- FCF Yield
- -25.7%
- -9.14%
Taxes and interestIndustry
- Income Tax
- $1.09M
- $74.00K
Scores and fair valueIndustry
- Altman Z-Score
- 2.10
- 0.31
- Piotroski F-Score
- 4
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | DBVT | S&P 500 | Difference | DBVT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +19.7% | -2.7% | +22.4 pts | ||
| 3 months | -19.2% | -1.7% | −17.4 pts | ||
| Year to date | -40.4% | +11.9% | −52.3 pts | ||
| 1 year | -17.0% | +12.0% | −29.0 pts | ||
| 3 years | +501.6% | +78.2% | +423.4 pts | +81.9% | +21.2% |
| 5 years | +85.0% | +73.2% | +11.7 pts | +13.1% | +11.6% |
| 10 years | -84.5% | +309.6% | −394.1 pts | -17.0% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
1M DBVT shares were sold short on Oct 30, 2026, down 7.5% from the previous report. At recent volumes it would take 1.7 days to buy them back. Over the last 20 sessions, 35.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 806,674 | -7.5% | 483,590 | 1.7 |
| Oct 15, 2026 | 872,075 | -22.4% | 438,225 | 2.0 |
| Sep 30, 2026 | 1,124,201 | -16.9% | 285,034 | 3.9 |
| Sep 15, 2026 | 1,353,244 | -14.6% | 410,543 | 3.3 |
| Aug 31, 2026 | 1,583,924 | -3.0% | 163,289 | 9.7 |
| Aug 14, 2026 | 1,633,383 | -11.7% | 411,320 | 4.0 |
| Jul 31, 2026 | 1,848,774 | +25.7% | 370,293 | 5.0 |
| Jul 15, 2026 | 1,470,719 | +13.2% | 187,661 | 7.8 |
| Jun 30, 2026 | 1,299,136 | -8.7% | 352,048 | 3.7 |
| Jun 15, 2026 | 1,423,044 | -14.6% | 259,294 | 5.5 |
| May 29, 2026 | 1,666,927 | -7.5% | 282,436 | 5.9 |
| May 15, 2026 | 1,801,328 | -0.8% | 179,255 | 10.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?